Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee Arthritis
SYNC01- P4
1 other identifier
observational
167
1 country
1
Brief Summary
Development of a new Patient Reported Outcome Measure (PROM) to assess patient's emotional wellbeing, and perceptions of Total Knee Replacement surgery for the treatment of knee arthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2024
CompletedFirst Posted
Study publicly available on registry
September 5, 2024
CompletedStudy Start
First participant enrolled
October 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2026
CompletedApril 1, 2026
November 1, 2025
11 months
September 3, 2024
March 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validate final questionnaire
Validation of final questionnaire
From first post-op visit to 12month follow-up
Study Arms (1)
Main patient Group
Patients who have undergone Total Knee Replacement (TKR) Surgery
Eligibility Criteria
Patients who are due to undergo TKR surgery or have undergone TKR surgery in the last 3 months.
You may qualify if:
- Patients aged 18 years of age or older.
- Patients who have undergone Total Knee Replacement surgery with a metal implant for the treatment of end-stage knee arthritis in the last 3 months.
- Patients who have only undergone one Total Knee Replacement surgery on the index knee.
- Patients who, in the opinion of the Investigator, are able to understand this project and co-operate with the requirements of participation.
- Patients who are able to give voluntary, written informed consent to participate in this project and from whom consent has been obtained.
You may not qualify if:
- Patients, who in the opinion of the Investigator, exhibit evidence of any condition or co-morbidity that would compromise their participation in the project.
- Patients who are unable to understand and communicate fluently in English.
- Patients who have experienced a complication following Total Knee Replacement surgery requiring a further hospital admission or revision surgery to the index knee.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Invibio Ltdlead
- Oxford University Innovationcollaborator
Study Sites (1)
Chapel Allerton Hospital
Leeds, LS7 4SA, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Professor Hemant Pandit
Leeds Teaching Hospitals NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2024
First Posted
September 5, 2024
Study Start
October 7, 2024
Primary Completion
September 9, 2025
Study Completion
April 14, 2026
Last Updated
April 1, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Only collated validated findings will be shared no individual data will be